Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-004965

Options or other derivatives

  • President & CEO acquired 115,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
USMAN NASSIM President & CEO 2020-01-23 Grant or award · Stock Option (Right to Buy) +115,000 115,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…